Abstract
An industry-based survey was conducted by the Global Alliance for Pediatric Therapeutics in February 2013 to determine and evaluate the current industry practices in the assessment of palatability and swallowability during the development of pediatric oral solid dosage forms, including the design and statistical analysis of such studies. In addition, the survey was designed to identify areas where regulatory guidance is most needed. The survey was distributed to 6 research-based pharmaceutical companies and to members of the American Academy of Pediatrics’ Provisional Section on Advances in Therapeutics and Technology. In general, while all responding companies have experience developing pediatric medicines, there was no consistent approach among respondents to the assessment of organoleptic properties of solid dosage forms, including excipients. In the direct assessment of palatability in pediatric patients in clinical trials, the survey identified that a variety of methods is used across companies, including visual analogue scales, simple and complex hedonic scales, and simplistic Likert-type scales. No assessment method identified was acknowledged as validated or with any statistical correlates, with many respondents stating that scales used in the pharmaceutical industry are adapted from the significant work conducted in the food service industry. Based on findings from the industry survey, the authors believe that there is an opportunity for consensus of the assessment of palatability and swallowability in the development of pediatric oral solid dosage forms.
Similar content being viewed by others
References
Adeyemi AO, Rascati KL, Lawson KA, Strassels SA. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis. Clin Ther. 2012;34:712–719.
LeLeiko NS, Lobato D, Hagin S, et al. Rates and predictors of oral medication adherence in pediatric patients with IBD. Inflamm Bowel Dis. 2013;19:832–839.
MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav. 2013;17:86–93.
Simons LE, McCormick ML, Mee LL, Blount RL. Parent and patient perspectives on barriers to medication adherence in adolescent transplant recipients. Pediatr Transplant. 2009;13:338–347.
Beck MH, Cataldo M, Slifer KJ, Pulbrook V, Guhman JK. Teaching children with attention deficit hyperactivity disorder (ADHD) and autistic disorder (AD) how to swallow pills. Clin Pediatr (Phila). 2005;44:515–526.
Tuleu C. Acceptability and palatability—methods available for assessment. In: Workshop on Paedriatric Formulations II for Assessors in National Regulatory Agencies. https://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2012/01/WC500121607.pdf. Published 2011. Accessed June 10, 2013.
Adams LV, Craig SR, Mmbaga EJ. Children’s medicines in Tanzania: a national survey of administration practices and preferences. PLoS ONE. 2013;8:e58303.
Davies EH, Tuleu C. Medicines for children: a matter of taste. J Pediatr. 2008;153:599–604.
Matsui D. Assessing the palatability of medications in children. Paediatr Perinatal Drug Therapy. 2007;8:55–60.
Simojoki K, Lillsunde P, Lintzeris N, Alho H. Bioavailability of buprenorphine from crushed and whole buprenorphine (subutex) tablets. Eur Addict Res. 2010;16:85–90.
Lippert C, Gbenado S, Qiu C, Lavin B, Kovacs SJ. The bioequivalence of telithromycin administered orally as crushed tablets versus tablets swallowed whole. J Clin Pharmacol. 2005;45:1025–1031.
Carrier MN, Garinot O, Vitzling C. Stability and compatibility of tegaserod from crushed tablets mixed in beverages and foods. Am J Health Syst Pharm. 2004;61:1135–1142.
Guinard JX. Sensory and consumer testing with children. Trends Food Sci Technol. 2000;11:273–283.
European Medicines Agency. Guideline on pharmaceutical development of medicines for paediatric use. https://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/06/WC500107908.pdf. Published 2011. Accessed June 3, 2013.
Noel GJ, Van Den Anker JN, Lombardi D, Ward R. Improving drug formulations for neonates: making a big difference in our smallest patients. J Pediatr. 2012;161:947–949.
Squires LA, Lombardi D, Sjostedt P, Thompson CA. A systematic literature review on the assessment of palatability and swallowability in the development of oral dosage forms for pediatric patients. Therapeutic Innovation & Regulatory Science. 2013;47(5):533–541.
Thompson C. Provisional section on advances in therapeutics and technology newsletter. PSATT Am Acad Pediatr. 2012;2:1–24.
Hames H, Seabrook JA, Matsui D, Rieder MJ, Joubert GI. A palatability study of a flavored dexamethasone preparation versus prednisolone liquid in children. Can J Clin Pharmacol. 2008;15:e95–e98.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thompson, C.A., Lombardi, D.P., Sjostedt, P. et al. Industry Survey on Current Practices in the Assessment of Palatability and Swallowability in the Development of Pediatric Oral Dosage Forms. Ther Innov Regul Sci 47, 542–549 (2013). https://doi.org/10.1177/2168479013500287
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479013500287